Picture of Grace Therapeutics logo

GRCE — Grace Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Acasti Announces Year-End 2024 Financial Results, Provides Business Update

June 21 (Reuters) - Acasti Pharma Inc  ACST.O :
    * ACASTI ANNOUNCES YEAR-END 2024 FINANCIAL RESULTS, PROVIDES
BUSINESS UPDATE
    * ACASTI PHARMA INC: PROJECTED CASH RUNWAY INTO SECOND
CALENDAR
QUARTER 2026
    * ACASTI PHARMA: PATIENT ENROLLMENT IN PIVOTAL STRIVE-ON
PHASE 3
SAFETY TRIAL FOR GTX-104 ON-TRACK FOR POTENTIAL NDA SUBMISSION
IN 1H CALENDAR 2025

Source text for Eikon:  ID:nGNX2dnDy4 
Further company coverage:  ACST.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Grace Therapeutics

See all news